节点文献
2015版《中国抗癌协会乳腺癌诊治指南与规范》:药物治疗策略的解读
Clinical Practice Guidelines in Breast Cancer by Chinese Anti-Cancer Association(2015 version ):interpretation of updates in terms of systemic treatment
【摘要】 为推动中国乳腺癌的规范化诊治,中国抗癌协会乳腺癌专业委员会于2007年发布了第1版《中国抗癌协会乳腺癌诊治指南与规范》(简称《指南》),并结合乳腺癌领域最新循证医学进展每2年进行1次更新,指导中国乳腺癌的诊断与治疗。最新公布的2015版《指南》从乳腺癌筛查、影像诊断、病理诊断、手术及全身治疗等方面对乳腺癌临床诊治策略进行了规范。本文从乳腺癌的内分泌治疗、抗HER-2分子靶向治疗、化疗与骨保护治疗的角度出发,对2015版《指南》药物治疗策略的更新内容进行了解读。
【Abstract】 In order to standardize the management of breast cancer,Chinese Anti-Cancer Association(CACA)issued the first edition of Clinical Practice Guidelines in Breast Cancer in 2007 and updates it every other year based on latest evidences. The newly published CACA Clinical Practice Guidelines in Breast Cancer in 2015 covers the overall management of breast cancer including screening,imaging,pathology,surgery and systemic treatment. This article mainly focused on the updates of systemic treatment for breast cancer patients in2015 version,with regard to endocrine therapy,anti-HER-2 molecular targeted therapy,chemotherapy and bone protection.
- 【文献出处】 中华乳腺病杂志(电子版) ,Chinese Journal of Breast Disease(Electronic Edition) , 编辑部邮箱 ,2016年02期
- 【分类号】R737.9
- 【被引频次】39
- 【下载频次】1166